Sedatives for staying still during long eye surgery
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests two sedative medications, remifentanil and remimazolam, to see which one better keeps patients still during long eye surgeries. It aims to make surgery safer and more comfortable for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You are having a long eye surgery (more than one hour) with a numbing injection around the eye.
- You are not taking blood thinners like aspirin or anticoagulants.
- You do not have uncontrolled high blood pressure, thyroid problems, or a frequent cough.
- You do not have a history of drug abuse, severe liver or kidney problems, or hearing loss.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two doses of ketamine (a medicine given through a vein) can reduce a reflex that slows the heart during eye surgery. If you are having eye surgery that involves moving the eye muscles, you may be eligible.
This study tests a sedative called Remimazolam for people having cataract surgery on both eyes. The goal is to see if it works well and safely for short procedures.
This trial tests whether a newer sedative (remimazolam) or a commonly used one (dexmedetomidine) is better at preventing delirium after planned heart surgery that requires a heart-lung machine. If you are having elective coronary bypass or valve surgery, you may be able to join.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This study tests a sedative, remimazolam, for older adults having their first cataract surgery. It aims to see if it helps keep patients comfortable and calm without needing general anesthesia.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
Hear when a new Long-Eye Surgeries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.